Production (Stage)
Eton Pharmaceuticals, Inc.
ETON
$14.30
-$0.21-1.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 17.42M | 14.94M | 20.26M | 17.69M | 16.66M |
| Total Receivables | 16.40M | 5.36M | 5.59M | 4.87M | 4.24M |
| Inventory | 13.62M | 15.23M | 1.94M | 2.07M | 2.32M |
| Prepaid Expenses | 2.52M | 5.49M | 1.96M | 799.00K | 1.05M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 49.96M | 41.02M | 29.75M | 25.43M | 24.26M |
|
|
|||||
| Total Current Assets | 49.96M | 41.02M | 29.75M | 25.43M | 24.26M |
| Net Property, Plant & Equipment | 180.00K | 209.00K | 226.00K | 255.00K | 131.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 33.88M | 34.88M | 5.85M | 6.12M | 6.39M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 12.00K | 12.00K | 12.00K | 12.00K | 12.00K |
| Total Assets | 84.03M | 76.12M | 35.84M | 31.82M | 30.79M |
|
|
|||||
| Total Accounts Payable | 4.87M | 4.17M | 2.68M | 2.13M | 2.26M |
| Total Accrued Expenses | 20.40M | 15.70M | 12.85M | 11.35M | 7.93M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 77.00K | 76.00K | 4.20M | 4.73M | 5.11M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 25.35M | 19.95M | 19.73M | 18.22M | 15.30M |
|
|
|||||
| Total Current Liabilities | 25.35M | 19.95M | 19.73M | 18.22M | 15.30M |
| Long-Term Debt | 29.99M | 29.81M | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 87.00K | 107.00K | 126.00K | 145.00K | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.15M | 1.83M | -- | -- | -- |
| Total Liabilities | 59.58M | 51.70M | 19.86M | 18.36M | 15.30M |
|
|
|||||
| Common Stock & APIC | 133.92M | 132.32M | 123.28M | 121.38M | 120.38M |
| Retained Earnings | -109.47M | -107.89M | -107.30M | -107.92M | -104.88M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 24.45M | 24.43M | 15.98M | 13.46M | 15.49M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 24.45M | 24.43M | 15.98M | 13.46M | 15.49M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 24.45M | 24.43M | 15.98M | 13.46M | 15.49M |
|
|
|||||